Literature DB >> 2986752

Antibody guided irradiation of brain glioma by arterial infusion of radioactive monoclonal antibody against epidermal growth factor receptor and blood group A antigen.

A A Epenetos, N Courtenay-Luck, D Pickering, G Hooker, H Durbin, J P Lavender, C G McKenzie.   

Abstract

In a patient with recurrent grade IV glioma of the brain resistant to conventional treatment an antibody guided isotopic scan showed uptake by the tumour of a monoclonal antibody (9A) that was developed against epidermal growth factor receptor but cross reacted with blood group A antigen. As a therapeutic attempt antibody labelled with 1665 MBq (45.0 mCi) iodine-131 was delivered to the tumour area by infusion into the internal carotid artery. Computed tomography showed regression of the tumour after treatment, and an appreciable and sustained clinical improvement was noted without any toxicity. Delivery of irradiation guided by monoclonal antibody delivered by arterial infusion of the tumour area may be of clinical value in the treatment of brain gliomas resistant to conventional forms of treatment.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2986752      PMCID: PMC1415686          DOI: 10.1136/bmj.290.6480.1463

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  13 in total

Review 1.  Combined modality therapy for intracranial tumors.

Authors:  H J Bloom
Journal:  Cancer       Date:  1975-01       Impact factor: 6.860

2.  High dose radiation therapy in the treatment of malignant gliomas: final report.

Authors:  O M Salazar; P Rubin; M L Feldstein; R Pizzutiello
Journal:  Int J Radiat Oncol Biol Phys       Date:  1979-10       Impact factor: 7.038

3.  Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses.

Authors:  H S Chen; J F Gross
Journal:  Cancer Treat Rep       Date:  1980-01

4.  Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences.

Authors:  J Downward; Y Yarden; E Mayes; G Scrace; N Totty; P Stockwell; A Ullrich; J Schlessinger; M D Waterfield
Journal:  Nature       Date:  1984 Feb 9-15       Impact factor: 49.962

5.  The history and progress of serologic immunotherapy and radiodiagnosis.

Authors:  S E Order
Journal:  Radiology       Date:  1976-01       Impact factor: 11.105

6.  Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.

Authors:  M D Walker; E Alexander; W E Hunt; C S MacCarty; M S Mahaley; J Mealey; H A Norrell; G Owens; J Ransohoff; C B Wilson; E A Gehan; T A Strike
Journal:  J Neurosurg       Date:  1978-09       Impact factor: 5.115

7.  Diagnosis of and therapy for solid tumors with radiolabeled antibodies and immune fragments.

Authors:  J A Carrasquillo; K A Krohn; P Beaumier; R W McGuffin; J P Brown; K E Hellström; I Hellström; S M Larson
Journal:  Cancer Treat Rep       Date:  1984-01

8.  Expression of epidermal growth factor receptors in human brain tumors.

Authors:  T A Libermann; N Razon; A D Bartal; Y Yarden; J Schlessinger; H Soreq
Journal:  Cancer Res       Date:  1984-02       Impact factor: 12.701

9.  Nerve growth factor receptors on human melanoma cells in culture.

Authors:  R N Fabricant; J E De Larco; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

10.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

View more
  24 in total

1.  Radioimmunotargeting of malignant glioma by monoclonal antibody D2C7 reactive against both wild-type and variant III mutant epidermal growth factor receptors.

Authors:  Michael R Zalutsky; Abraham Boskovitz; Chien-Tsun Kuan; Charles N Pegram; Joanne Ayriss; Carol J Wikstrand; Anne F Buckley; Eric S Lipp; James E Herndon; Roger E McLendon; Darell D Bigner
Journal:  Nucl Med Biol       Date:  2011-09-29       Impact factor: 2.408

Review 2.  Monoclonal antibodies. Future potential in cancer chemotherapy.

Authors:  C Kosmas; H Kalofonos; A A Epenetos
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

Review 3.  Neuro-oncology index and review (adult primary brain tumors). Radiotherapy, chemotherapy, immunotherapy, photodynamic therapy.

Authors:  M S Mahaley
Journal:  J Neurooncol       Date:  1991-10       Impact factor: 4.130

Review 4.  Planning for intracavitary anti-EGFR radionuclide therapy of gliomas. Literature review and data on EGFR expression.

Authors:  J Carlsson; Z P Ren; K Wester; A L Sundberg; N E Heldin; G Hesselager; M Persson; L Gedda; V Tolmachev; H Lundqvist; E Blomquist; M Nistér
Journal:  J Neurooncol       Date:  2006-03       Impact factor: 4.130

5.  Application of invasive microwave hyperthermia for the treatment of gliomas.

Authors:  H L Wen; J S Dahele; Z D Mehal; W H Chan; D Y Wen
Journal:  J Neurooncol       Date:  1988       Impact factor: 4.130

6.  Monocyte subpopulations in human gliomas: expression of Fc and complement receptors and correlation with tumor proliferation.

Authors:  T Morimura; C Neuchrist; K Kitz; H Budka; O Scheiner; D Kraft; H Lassmann
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

7.  Intralesional administration of I-131 labelled monoclonal antibodies in the treatment of malignant gliomas.

Authors:  A Arista; C Sturiale; P Riva; V Tison; M Frattarelli; G Moscatelli; G Franceschi; A Spinelli
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

8.  Effects of 131I-EGF on cultured human glioma cells.

Authors:  J Capala; M Pråhl; S Scott-Robson; J Pontén; B Westermark; J Carlsson
Journal:  J Neurooncol       Date:  1990-12       Impact factor: 4.130

9.  Construction of an immunotoxin, D2C7-(scdsFv)-PE38KDEL, targeting EGFRwt and EGFRvIII for brain tumor therapy.

Authors:  Vidyalakshmi Chandramohan; Xuhui Bao; Stephen T Keir; Charles N Pegram; Scott E Szafranski; Hailan Piao; Carol J Wikstrand; Roger E McLendon; Chien-Tsun Kuan; Ira H Pastan; Darell D Bigner
Journal:  Clin Cancer Res       Date:  2013-07-15       Impact factor: 12.531

10.  Effects of EGF-dextran-tyrosine-131I conjugates on the clonogenic survival of cultured glioma cells.

Authors:  A Andersson; J Capala; J Carlsson
Journal:  J Neurooncol       Date:  1992-11       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.